Replies to post #2224 on Enanta Pharmaceuticals Inc (ENTA)

[DewDiligence]

ENTA’s enterprise value at the current share price ($51.50) is about $900M. This is based on 24.7M fully-diluted shares (#msg-168831164) and pro forma cash of $353.3M (#msg-168831159), both figures as of 3/31/22.

[DewDiligence]

ENTA’s fully-diluted share count @6/30/22=24.7M—unchanged since 3/31/22 (#msg-168831164).

The 24.7M figure above consists of: 20.7M basic shares on the 6/30/22 balance sheet (https://www.sec.gov/ix?doc=/Archives/edgar/data/0001177648/000095017022015515/enta-20220630.htm#consolidated_balance_sheets ); and 4.0M options outstanding at 6/30/22 (whether or not exercisable) (ibid, p.12).